---
schema_version: "secwatch.filing_event.v1"
accession: "0001638833-21-000144"
form_type: "8-K"
ticker: "SGRY"
cik: "0001638833"
company_name: "Surgery Partners, Inc."
filed_at: "2021-11-02T23:59:59+00:00"
generated_at: "2026-06-28T15:11:56.687362+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Surgery Partners Q3 revenue up 12.7% to $559.2M; raises FY EBITDA guidance to $325-330M

## Summary
- Revenue $559.2M (+12.7% YoY); net loss $22.9M; adjusted EBITDA $76.4M (+25% YoY).
- Same-facility revenue +8.3%, case volume +6.2% vs prior year quarter.
- FY 2021 adjusted EBITDA guidance raised to $325M-$330M.
- Deployed over $130M on acquisitions YTD; 3 ASCs bought in Aug; $225M under LOI.
- Cash $330.4M; revolver capacity $163M; net debt/EBITDA ratio 6.25x.

## SEC filing metadata
- accession: 0001638833-21-000144
- form_type: 8-K
- ticker: SGRY
- cik: 0001638833
- company_name: Surgery Partners, Inc.
- filed_at: 2021-11-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1638833/000163883321000144/0001638833-21-000144-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1638833/000163883321000144/sgry-20211102.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001638833-21-000144
- JSON: https://secwatch.observer/filing/0001638833-21-000144.json
- Plain text: https://secwatch.observer/filing/0001638833-21-000144.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.